- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
2020–2025 · program · P50
Pathology Core
David Kolin · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2026 · research · R35
Structure, mechanism, and pharmacology of BRAF and its partners in the RAS/RAF/MAP kinase pathway
Michael J Eck · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · career development · K08
Mechanistic Determinants of Follicular-Helper T-cell Lymphomagenesis
Samuel Yao-Ming Ng · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2025 · research · R01
Biomarker screening algorithms for the improved early detection of hepatocellular carcinoma
Nabihah Tayob · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2026 · research · R35
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers
Thomas M Roberts · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2023 · research · R01
Expression and Impact of Interspersed Repeats
Kathleen H Burns · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2025 · cooperative agreement · UH3
Assay Validation of a Circulating miRNA Test for Diagnosis and Monitoring of Malignant Germ Cell Tumors
Anne Lindsay Frazier · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · research · R01
The Function of CDK5 in Metastasis
Peter Sicinski · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · program · P01
Immune Modulation After Allogeneic HCT
Robert Jon Soiffer · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2026 · research · R35
Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations
James A. Decaprio · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2026 · research · R35
Reading mitochondrial apoptotic signaling to identify active cancer therapeutics
Anthony G Letai · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · research · R01
Cellular and Biochemical Pathways of Adipose Metabolism and Thermogenesis
Bruce M. Spiegelman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2023 · research · R01
Cellular and Biochemical Pathways of Adipose Metabolism and Thermogenesis
Bruce M. Spiegelman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2022 · fellowship · F32
Mismatch Repair Proteins as Drivers of Temozolomide Resistance in Glioblastoma
Adam Nathaniel Boynton · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019 · award
Elucidating the role of SHOC2 to enhance MEK inhibitor sensitivity in PDAC
Jason Kwon · Dana-Farber Cancer Institute · funded by American Cancer Society
2019–2020 · research · R01
MRI-Photoacoustic-Raman Nanostars for Pre- and Intraoperative Multimodal Imaging
Moritz Florian Kircher · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2023 · research · R01
Genetic dissection of visceral pain pathways
Qiufu Ma · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2026 · research · R35
Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations
James A. Decaprio · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2023 · research · R01
Genetic dissection of visceral pain pathways
Qiufu Ma · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2025 · cooperative agreement · UH3
Assay Validation of a Circulating miRNA Test for Diagnosis and Monitoring of Malignant Germ Cell Tumors
Anne Lindsay Frazier · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2023 · research · R01
Approaches to inducing broadly neutralizing antibodies with immunogens mimicking steric occlusion of the MPER as configured on the HIV-1 virion surface
Mikyung Kim · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2021 · award
Patient-Centered Communication in Ovarian Cancer Care
Rachel Pozzar · Dana-Farber Cancer Institute · funded by American Cancer Society
2019–2023 · research · R01
Expression and Impact of Interspersed Repeats
Kathleen H Burns · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · career development · K08
Expectations for Pediatric Cancer Treatment (EXPECT): A Family-Centered Intervention to Prepare Parents for Pediatric Leukemia Therapy
Katie A. Greenzang · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2026 · research · R35
Reading mitochondrial apoptotic signaling to identify active cancer therapeutics
Anthony G Letai · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · cooperative agreement · U24
Developing Informatics Technologies to Model Cancer Gene Regulation
Clifford Meyer · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2023 · research · R01
Cellular and Biochemical Pathways of Adipose Metabolism and Thermogenesis
Bruce M. Spiegelman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2021 · award
Targeting Transcriptional Regulation in Ovarian Cancer
Isaac Klein · Dana-Farber Cancer Institute · funded by American Cancer Society
2019–2024 · cooperative agreement · U24
Developing Informatics Technologies to Model Cancer Gene Regulation
Clifford Meyer · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · award
A novel cytotoxic CD4+ T cell approach for treating B cell malignancies -R1
Baochun Zhang · Dana-Farber Cancer Institute · funded by American Cancer Society
2019–2026 · research · R35
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers
Thomas M Roberts · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · research · R01
Approaches to inducing broadly neutralizing antibodies with immunogens mimicking steric occlusion of the MPER as configured on the HIV-1virion surface
Mikyung Kim · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2025 · research · R01
Biomarker screening algorithms for the improved early detection of hepatocellular carcinoma
Nabihah Tayob · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2022 · career development · K22
Noninvasive monitoring and evaluation of anti-tumor responses as a predictive tool
Mohammad Rashidian · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2026 · research · R01
Biomarker screening algorithms for the improved early detection of hepatocellular carcinoma
Nabihah Tayob · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · research · R01
Defining mechanisms of succinate regulation over adipose tissue thermogenesis
Edward Thomas Chouchani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2022 · grant · KCRP
Host Immune Signatures as Therapy Response Biomarkers in Metastatic Renal Cell Carcinoma
Toni Choueiri · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2019–2021 · fellowship · F32
Mechanism of activation of a new cGAS-like enzyme in humans
Benjamin Robert Morehouse · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2023 · research · R01
Incomplete Penetrance via Edgetic Suppression
Michael A Calderwood · Dana-Farber Cancer Institute · funded by National Institutes of Health
2019–2024 · program · P01
Informed Combination Strategies for Peripheral T-cell Lymphomas
Birgit Knoechel · Dana-Farber Cancer Institute · funded by National Institutes of Health
